T1	PROC 46 71	Seguimiento a largo plazo
#1	AnnotatorNotes T1	C1517942; Long-term Follow-up; Health Care Activity
T2	CHEM 90 103	darvadstrocel
#2	AnnotatorNotes T2	C5227825; Darvadstrocel; Pharmacologic Substance
T3	PROC 110 121	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 125 144	fístulas perianales
#4	AnnotatorNotes T4	C0267561; Perianal fistula; Anatomical Abnormality
T5	PROC 177 214	Seguimiento de un estudio en fase III
T6	PROC 220 254	evaluar la eficacia y la seguridad
#5	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	PROC 292 303	tratamiento
#6	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	DISO 307 326	fístulas perianales
#7	AnnotatorNotes T8	C0267561; Perianal fistula; Anatomical Abnormality
T9	DISO 355 374	enfermedad de Crohn
#8	AnnotatorNotes T9	C0010346; Crohn Disease; Disease or Syndrome
T10	CHEM 272 285	darvadstrocel
#9	AnnotatorNotes T10	C5227825; Darvadstrocel; Pharmacologic Substance
T11	PROC 442 453	Tratamiento
#10	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 459 478	fístulas perianales
#11	AnnotatorNotes T12	C0267561; Perianal fistula; Anatomical Abnormality
T13	DISO 485 504	enfermedad de Crohn
#12	AnnotatorNotes T13	C0010346; Crohn Disease; Disease or Syndrome
T14	DISO 531 550	Fístulas perianales
#13	AnnotatorNotes T14	C0267561; Perianal fistula; Anatomical Abnormality
T15	DISO 557 576	enfermedad de Crohn
#14	AnnotatorNotes T15	C0010346; Crohn Disease; Disease or Syndrome
T16	PROC 822 831	protocolo
#15	AnnotatorNotes T16	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T17	PROC 1013 1026	procedimiento
#16	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T18	CHEM 1479 1503	fármaco en investigación
#17	AnnotatorNotes T18	C0013230; Investigational New Drugs; Pharmacologic Substance
T19	ANAT 134 144	perianales
#18	AnnotatorNotes T19	C0442158; Perianal; Body Location or Region
T20	ANAT 316 326	perianales
#19	AnnotatorNotes T20	C0442158; Perianal; Body Location or Region
T21	ANAT 468 478	perianales
#20	AnnotatorNotes T21	C0442158; Perianal; Body Location or Region
T22	ANAT 540 550	perianales
#21	AnnotatorNotes T22	C0442158; Perianal; Body Location or Region
T23	Date 13 17	2019
T24	Date 58 71	a largo plazo
T25	Date 255 268	a largo plazo
T26	LIVB 341 350	pacientes
#22	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 626 635	pacientes
#23	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 746 758	investigador
#24	AnnotatorNotes T28	C0035173; Research Personnel; Professional or Occupational Group
T29	LIVB 763 771	paciente
#25	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 839 847	paciente
#26	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	LIVB 870 889	representante legal
#27	AnnotatorNotes T31	C4288823; Legal Representative for the Study; Human
T32	LIVB 1046 1054	paciente
#28	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T34	LIVB 1172 1181	pacientes
#29	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T37	Duration 1254 1268	más de 3 meses
T38	LIVB 1282 1290	paciente
#30	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Duration 1362 1381	los últimos 3 meses
T41	PHYS 784 792	entender
#31	AnnotatorNotes T41	C0162340; Comprehension; Mental Process
#32	AnnotatorNotes T24	C0443252; Long-term; Temporal Concept
#33	AnnotatorNotes T5	C0282461; Phase 3 Clinical Trials; Research Activity + C1522577; Follow up; Health Care Activity
#34	AnnotatorNotes T25	C0443252; Long-term; Temporal Concept
T33	Neg_cue 1182 1184	no
T35	Observation 1191 1228	aptos para su inclusión en el estudio
A1	Assertion T35 Negated
#35	AnnotatorNotes T35	C1302261; Patient eligible for clinical trial; Finding (?)
T36	Neg_cue 1127 1129	no
T40	Observation 1130 1139	se retiró
#36	AnnotatorNotes T40	C0422727; Patient withdrawn from trial; Finding (?)
A2	Assertion T40 Negated
T42	Observation 1055 1083	ha participado en el estudio
#37	AnnotatorNotes T42	C1278516; Patient participation status; Finding
T43	Quantifier_or_Qualifier 327 336	complejas
#38	AnnotatorNotes T43	C0439855; Complex; Qualitative Concept
R1	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T43	
R2	Location_of Arg1:T20 Arg2:T8	
R3	Location_of Arg1:T19 Arg2:T4	
T44	Quantifier_or_Qualifier 145 154	complejas
#39	AnnotatorNotes T44	C0439855; Complex; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T44	
R5	Used_for Arg1:T2 Arg2:T3	
R6	Used_for Arg1:T10 Arg2:T7	
R7	Overlap Arg1:T6 Arg2:T25	
R8	Overlap Arg1:T1 Arg2:T24	
R9	Experiences Arg1:T26 Arg2:T10	
R10	Experiences Arg1:T26 Arg2:T8	
R11	Experiences Arg1:T26 Arg2:T9	
T45	Observation 379 408	han participado en el estudio
A3	Status T45 History_of
#40	AnnotatorNotes T45	C1278516; Patient participation status; Finding
R13	Before Arg1:T45 Arg2:T6	
R14	Location_of Arg1:T21 Arg2:T12	
R15	Overlap Arg1:T8 Arg2:T9	
R16	Overlap Arg1:T12 Arg2:T13	
R17	Overlap Arg1:T14 Arg2:T15	
R18	Location_of Arg1:T22 Arg2:T14	
T46	CONC 661 685	incorporación al estudio
#41	AnnotatorNotes T46	C1512693; Inclusion; Qualitative Concept
T47	Observation 606 635	elegibilidad de los pacientes
#42	AnnotatorNotes T47	C1302261; Patient eligible for clinical trial; Finding
R20	Before Arg1:T47 Arg2:T46	
T48	Observation 775 817	capaz de entender y cumplir los requisitos
R21	Experiences Arg1:T29 Arg2:T41	
R22	Overlap Arg1:T41 Arg2:T16	
R23	Overlap Arg1:T48 Arg2:T16	
T49	Observation 890 895;904 910	firma un FCI
#43	AnnotatorNotes T49	C0742766; consent signed; Finding (?)
R24	Negation Arg1:T36 Arg2:T40	
R25	Before Arg1:T49 Arg2:T17	
T50	Observation 1105 1115	finalizado
#44	AnnotatorNotes T50	C2732579; Completion of clinical trial; Finding
R26	Before Arg1:T42 Arg2:T50	
R27	Negation Arg1:T33 Arg2:T35	
R28	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T35	
T51	Observation 1291 1310	finalizó el estudio
#45	AnnotatorNotes T51	C2732579; Completion of clinical trial; Finding
R29	Before Arg1:T51 Arg2:T37	
T52	CONC 1394 1417	inclusión en el estudio
#46	AnnotatorNotes T52	C1512693; Inclusion; Qualitative Concept
R33	After Arg1:T52 Arg2:T39	
R34	Before Arg1:T18 Arg2:T39	
R35	Before Arg1:T18 Arg2:T52	
T53	Neg_cue 1505 1512	excepto
T54	CONC 1513 1552	antes de la participación en el estudio
A4	Assertion T54 Negated
R36	Negation Arg1:T53 Arg2:T54	
T55	Quantifier_or_Qualifier 1428 1436	previsto
#47	AnnotatorNotes T55	C1301732; Planned; Functional Concept
T56	PROC 1458 1465	estudio
#48	AnnotatorNotes T56	C0008976; Clinical Trials; Research Activity
R37	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T55	
R38	Overlap Arg1:T55 Arg2:T56	
R39	Before Arg1:T42 Arg2:T40	
R30	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T48	
#49	AnnotatorNotes T54	C5421123; Prior to Study; Functional Concept
A5	Experiencer T38 Patient
A6	Experiencer T34 Patient
A7	Status T18 Future
A8	Experiencer T26 Patient
A9	Experiencer T27 Patient
A10	Experiencer T28 Other
A11	Experiencer T29 Patient
A12	Experiencer T30 Patient
A13	Experiencer T31 Other
A14	Experiencer T32 Patient
